• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryRoe v. Wade

With Roe v. Wade out, we need male contraception more than ever

By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
By
Akash Bakshi
Akash Bakshi
Down Arrow Button Icon
July 29, 2022, 6:15 AM ET
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.
Hormonal contraceptive methods for women come with side effects such as mood changes, depression, an increased risk of breast and cervical cancer, and blood clots. But when it comes to men, it is widely assumed side effects would be unacceptable.Getty Images

Roe v. Wade has been overturned, resulting in reduced access to safe and effective abortions. It’s a devastating moment for the health and well-being of American women and individuals who can become pregnant.

We should consider why women need abortions in the first place. For many (but not all–some women require abortions for medical reasons), it’s unintended pregnancy. For every two pregnant women in America, one of their pregnancies is unintended. About 40% of those women choose to have an abortion, which is now outlawed in as many as 28 states in America. 

But unplanned isn’t a synonym for unprotected. As many as 50% of couples observed in a study by the Guttmacher Institute were actively using a contraceptive when they became pregnant. It won’t be a surprise to learn that condoms are behind many well-intentioned yet failed efforts to prevent pregnancy. The pill, too, can fail: 12% of women who seek an abortion were on the pill. 

Of course, the protections previously granted by Roe must be codified into law. But we also need better contraceptives. We always have. We need to empower people to prevent unwanted pregnancy and the need for abortion. We can also increase access to highly effective contraceptives and bring men into the conversation. After all, women don’t get pregnant alone.  

Efficacy aside, nearly every woman who is on a hormonal contraceptive weighs side effects that include mood changes, depression, an increased risk of breast and cervical cancer, and blood clots.

Male birth control doesn’t exist today beyond the technologies developed in the 1800s: condoms, which come with high failure rates, or vasectomies, which aren’t yet reliably reversible. But if it did, we could decrease unintended pregnancies and, in today’s America, unsafe abortions. 

We need men to claim their full equal responsibility for reproductive health–and it’s not an unrealistic notion. Nearly 75% of women and about 72% of men believe both sexual partners should be equally responsible for birth control. There is a massive untapped market for novel male contraceptives that are highly effective, reversible, and convenient to use. There is also a glaring gap in interest, research, and funding in the field of male reproduction. Biologically, it’s challenging: successful contraception requires us to stop millions of sperm from reaching an egg, and it’s difficult to target human sperm cells.

To suggest that men aren’t looking beyond the condom simply doesn’t reflect the current mood: A recent survey showed that 17 million American men are seeking better contraceptive methods for themselves. 

This wasn’t always the case, of course: It’s widely believed that demand for male contraceptive methods didn’t exist until after paternity tests were developed, putting men on the hook for raising their own offspring.

Regardless, it’s a whole new era for heterosexual women and their relationship with male partners. The #MeToo movement and the 2017 Women’s March on Washington come to mind as flashpoints for modern feminism which aim to hold the country’s most powerful men to account and include a focus on sexual empowerment centered on women’s pleasure. 

Still, many assumed men would be turned off by the possibility of side effects, which suggests a gross double standard in which side effects are acceptable for women but unacceptable for men–a notion that also does not align with the values that younger generations are striving for. 

Let’s empower men to step up during a moment when women’s access to safe and effective abortions is now in grave danger. 

An affordable, reversible contraceptive for men is possible. Private companies are commercializing therapeutics and devices that non-hormonally bring sperm counts below fertile limits in men, essentially offering the benefits of a highly effective contraceptive to men. Other institutions are trialing hormonal methods with tentatively promising efficacy. 

These developments give me hope that someday we can decrease the hormonal burden we put on women in the name of preventing pregnancy. It’s a burden that has compelled so many women to share their stories with me about the effects of birth control on their lives. It’s personal and real. The development of male contraceptives covered by insurance and widely adopted by men can radically change that.

Attacks on reproductive autonomy and a lack of male birth control have put women in devastating positions. But if we’re to decrease the need for abortion, we’ll need men to take on a fair share of responsibility in preventing unwanted pregnancies–and a whole lot of research, funding, and awareness to get us there.

Akash Bakshi is the CEO and co-founder of YourChoice Therapeutics, a company that is developing a birth control pill for men. Akash holds degrees in Biochemistry and Cell Biology from UC San Diego and University of Queensland.

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not reflect the opinions and beliefs of Fortune.

More must-read commentary published by Fortune:

  • COVID got me. Will it come for you?
  • Why remote work will win this fall
  • A list of companies supporting abortion rights after the Roe v. Wade ruling shows which firms are stepping up, and why
  • Career hoarding is on the rise—but it comes at a cost
  • Venture capital is hard–and it’s supposed to be

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Akash Bakshi
See full bioRight Arrow Button Icon

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

manyika
CommentaryScience
AI is transforming science – more researchers need access to these powerful tools for discovery  
By James Manyika and Demis HassabisFebruary 16, 2026
16 hours ago
isom
CommentaryAirline industry
The skies for American Airlines are clearer than you think
By Jeffrey Sonnenfeld and Steven TianFebruary 16, 2026
16 hours ago
AsiaGreat Place to Work
Southeast Asia’s fast-growing hospitality industry has a people problem. Here’s what leading brands are doing to get the staff they need
By Alice Williams and Great Place To WorkFebruary 15, 2026
1 day ago
white lotus
CommentaryLuxury
Elites are the villains we love to hate. It’s American culture’s most paradoxical obsession
By Alexa BeckFebruary 15, 2026
2 days ago
haque
CommentarySocial Media
I’m the CEO of the 1980s most viral restaurant, Tony Roma’s. We’re still thriving but viral brands keep turning into pumpkins
By Mina HaqueFebruary 15, 2026
2 days ago
hawkinson
CommentaryInfrastructure
Your essential services are one surprise failure away from disruption. Consider how physical AI could tackle the crisis
By Alex HawkinsonFebruary 14, 2026
3 days ago

Most Popular

placeholder alt text
Economy
Social Security's trust fund is nearing insolvency, and the borrowing binge that may follow will rip through debt markets, economist warns
By Jason MaFebruary 15, 2026
1 day ago
placeholder alt text
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of your class and drop out
By Sasha RogelbergFebruary 14, 2026
3 days ago
placeholder alt text
Real Estate
A billionaire and an A-list actor found refuge in a 37-home Florida neighborhood with armed guards—proof that privacy is now the ultimate luxury
By Marco Quiroz-GutierrezFebruary 15, 2026
2 days ago
placeholder alt text
Success
Meet the grandmother living out of a 400-ft ‘granny pod’ to save money and help with child care—it’s become an American ‘economic necessity’
By Emma BurleighFebruary 15, 2026
2 days ago
placeholder alt text
Economy
A U.S. 'debt spiral' could start soon as the interest rate on government borrowing is poised to exceed economic growth, budget watchdog says
By Jason MaFebruary 14, 2026
2 days ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
6 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.